Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | AR | P10275 | 5/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29268863 | 0.84 | AR (0.57) | TDP1CYP3A4SMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL27588383 | 0.83 | ALDH1A1 (0.39) | ALOX15TDP1CYP3A4SMN1; SMN2TP53 | |
| SCHEMBL249865 | 0.82 | CYP3A4 (0.52) | ALOX15TDP1CYP3A4SMN1; SMN2TP53 | |
| SCHEMBL28967100 | 0.81 | CYP3A4 (0.56) | ALOX15TDP1CYP3A4SMN1; SMN2TP53 | |
| SCHEMBL1003862 | 0.78 | ALDH1A1 (0.46) | ALDH1A1KDM4EUSP2ARCYP2A6 | |
| SCHEMBL29038173 | 0.77 | TDP1 (0.52) | ALOX15TDP1CYP3A4SMN1; SMN2TP53 | |
| SCHEMBL7289054 | 0.77 | TDP1 (0.52) | ALOX15TDP1CYP3A4SMN1; SMN2TP53 | |
| SCHEMBL2028221 | 0.76 | KDM4E (0.55) | TDP1CYP3A4SMN1; SMN2ALDH1A1HSD17B10 | |
| SCHEMBL277588 | 0.76 | TSHR (0.52) | ALOX15TDP1TP53ALDH1A1HSD17B10 | |
| SCHEMBL5070146 | 0.76 | MEN1 (0.48) | ALOX15TDP1CYP3A4SMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 392 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119176746-B | Method for preparing bisphenol A and heterocyclic compound by using waste PC | 浙江大学 | 2025-05-30 | — | — | CN | claimed |
| CN-119176746-A | Method for preparing bisphenol A and heterocyclic compound by using waste PC | 浙江大学 | 2024-12-24 | — | — | CN | claimed |
| CN-109232366-B | Preparation method and application of 2-acyl-3-aminoindole compound | 华中师范大学 | 2020-08-21 | — | — | CN | claimed |
| CN-106946800-B | A kind of synthetic method of -2,4 (1H, 3H)-diketone of quinazoline and its derivative | 华东师范大学 | 2019-11-15 | — | — | CN | claimed |
| EP-1773768-B1 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | EXELIXIS INC (US) | 2018-08-22 | — | — | EP | claimed |
| CN-102797043-B | Medicinal molecular fragment library and construction process thereof | Tianli (Tianjin) Technology Co., Ltd. (CN) | 2015-11-25 | — | — | CN | claimed |
| CN-102797043-A | Medicinal molecular fragment library and construction method thereof | CBB NETWORK CO LTD | 2012-11-28 | — | — | CN | claimed |
| CN-101805498-B | Polylactic acid combination containing sulfonic acid compound and nitrogenous organic compound and preparation method thereof | TORAY FIBER RES INST CN CO LTD | 2012-08-15 | — | — | CN | claimed |
| CN-101921389-A | Preparation method of polyactic acid composite containing mono-sulfoacid and nitrogenous organic compound | TORAY FIBER RES INST CN CO LTD | 2010-12-22 | — | — | CN | claimed |
| CN-101805498-A | Polylactic acid combination containing sulfonic acid compound and nitrogenous organic compound and preparation method thereof | TORAY FIBER RES INST CN CO LTD | 2010-08-18 | — | — | CN | claimed |
| US-7547713-B2 | O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives | GU LIANQUAN | 2009-06-16 | — | — | US | claimed |
| EP-1773768-A4 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | EXELIXIS INC (US) | 2008-08-06 | — | — | EP | claimed |
| EP-1773768-A2 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | Exelixis, Inc. (US) | 2007-04-18 | — | — | EP | claimed |
| US-20060111405-A1 | O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives | GU LIANQUAN | 2006-05-25 | — | — | US | claimed |
| WO-2006012642-A2 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | EXELIXIS, INC. (US) | 2006-02-02 | — | — | WO | claimed |
| EP-1422218-A1 | ANTIVIRAL AGENT | SHIONOGI & CO., LTD. (JP) | 2004-05-26 | — | — | EP | claimed |
| US-6336963-B1 | INK COMPOSITION COMPRISING INK VEHICLE COMPRISING FIRST NITRILE COMPOUND HAVING FIRST VISCOSITY AT MELT TEMPERATURE, VISCOSITY MODIFIER COMPRISING SECOND NITRILE COMPOUND HAVING LOWER VISCOSITY AT MELT TEMPERATURE, COLORANT | XEROX CORPORATION | 2002-01-08 | — | — | US | claimed |
| CN-122036606-A | Synthesis method of aminoacridine compound | 南京工业大学 | 2026-05-15 | — | — | CN | disclosed |
| US-3992428-A | REACTING UREA AND HEXAMETHYLDISILAZANE IN THE PRESENCE OF A NITROGEN CONTAINING SALT | WACKER-CHEMIE GMBH (DT) | 1976-11-16 | — | — | US | disclosed |
| US-3987192-A | ANTIALLERGENS AND ANTIANAPHYLAXID; 2'-CYANO-OXANILIC ACID | THE UPJOHN COMPANY (US) | 1976-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060111405-A1 | O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives | PTGS2, PTGES2, PTGES | ALOX15 227/4885TDP1 3288/4885CYP3A4 32/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.